Advanced Filters
noise
Found 64,772 clinical trials

Bridge-Enhanced ACL Repair (BEAR) in Meniscus Repair

The bridge-enhanced ACL repair (BEAR) implant is a collagen-based scaffold loaded with whole blood. It is designed to promote healing in the setting of intraarticular knee pathology. This study would compare clinical outcomes and synovial fluid cytokine profiles in patients who undergo isolated meniscal repair with or without the BEAR …

18 - 75 years of age All Phase N/A

Tislelizumab in People With Colorectal Cancer

The researchers are doing this study to find out whether tislelizumab is an effective treatment for people with colorectal cancer who are living in Nigeria. The researchers will also look at the safety of the study drug. All participants in this study will be treatment naïve (they have not yet …

18 years of age All Phase 2
K Kelly Jenkins

VitD3 Supplementation in Patients With Multiple Myeloma

The goal of this clinical trial is to evaluate post-transplant immune reconstitution and lymphocyte recovery as well as the 3-year progression-free survival of patients with multiple myeloma in two treatment arms. One arm will receive Maintenance Vitamin D and the other arm will receive no maintenance Vitamin D prior to …

18 years of age All Phase N/A
C COLINE PERRIER, ARC

Diagnostic Efficacy of Connected WAtch ECG Versus External Holter ECG

Palpitations are a frequent reason for consultation (16% of total volume) and management in the emergency department. Conventional diagnostic management in our establishment is based on a 48-hour external ECG holter, combined with a stress test if symptoms are triggered by physical activity. The diagnostic difficulty lies in the frequency …

18 years of age All Phase N/A
M Mohamed ElMeligie, Ph.D

HILT Dose Optimization for Knee Osteoarthritis Pain

This study aims to find the best settings (dose) for High-Intensity Laser Therapy (HILT) to reduce pain and improve function in people with moderate knee osteoarthritis. Participants will be randomly assigned to receive one of three different doses of HILT (low, medium, or high) or a sham (placebo) laser treatment, …

18 - 65 years of age All Phase N/A
E Eric Jacobsen, MD

Tazemetostat Plus CHOP in 1L T-cell Lymphoma

This research is being done to evaluate tazemetostat in combination with CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy as a possible treatment for peripheral T-Cell Lymphoma (PTCL). The name of the study drugs involved in this study are: Tazemetostat (a type of inhibitor for Enhancer of Zeste Homolog 2 (EZH2)) Standard …

18 years of age All Phase 2
K Katy Trinkley, PharmD, PhD

Evaluating the Reach of Clinical Decision Support for Patients With Heart Failure

To work best, clinical decision support tools (CDS) must be timed to provide support when healthcare decisions are made, which includes virtual visits (phone or video). Unfortunately, most CDS tools are either missing from virtual visits or not designed for the unique context of virtual visits (e.g., availability of physical …

18 years of age All Phase N/A
Y Yusuf Ozguner

Efficacy of Ultrasound-Guided Genicular Nerve Radiofrequency Ablation Therapy

The main symptom of knee osteoarthritis, which occurs after damage to the joint cartilage with age, is pain, but this symptom often becomes chronic. Current conservative treatments have moderate effects on chronic knee pain and their use is limited due to the risk of side effects. In addition to pain, …

30 - 75 years of age All Phase N/A

Exercise Reset for Concussion in a Military Environment

Our primary objective is to show that early, personalized aerobic exercise treatment safely improves concussion recovery, speeds RTD, and reduces persistent symptoms in CSM. Our secondary objectives include demonstrating the clinical utility of our March-in-place test and determining fundamental mechanisms for the effect of exercise rehabilitation on concussion recovery.

18 - 40 years of age All Phase N/A
A Angela Hotchkiss

A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

This is a Phase 1a/1b, open-label, dose escalation and expansion study to evaluate the safety and efficacy of CTIM-76 (study drug), a humanized T cell engaging bispecific antibody targeting CLDN6, in subjects with platinum-refractory/resistant ovarian cancer (PRROC) and other advanced CLDN6-positive solid tumors (i.e., testicular and endometrial).

18 years of age All Phase 1

Simplify language using AI